Impaired synaptogenesis and long-term modulation of behavior following postnatal elevation of GABA levels in mice

Neuropharmacology

Volumn 54, Issue 2, 2008, Pages 387-398

  Levav, Tamar ^a   Wirthaim, Orly ^a   Weiss, Reut ^a   Grossman, Yoram ^a   Golan, Hava ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antiepileptic drugs; Hippocampus; Synaptotagmin; VAMP II

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; SYNAPTOBREVIN 2; SYNAPTOTAGMIN; VIGABATRIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTOGENESIS;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CEREBRAL CORTEX; DYSTROPHIN-ASSOCIATED PROTEINS; ELECTROPHYSIOLOGY; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; RECOGNITION (PSYCHOLOGY); SYNAPSES; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS; VIGABATRIN;

EID: 38349038505     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.10.012     Document Type: Article

References (34)

1. Barker J.L., Behar T., Li Y.X., Liu Q.Y., Ma W., Maric D., Maric I., Schaffner A.E., Serafini R., Smith S.V., Somogyi R., Vautrin J.Y., Wen X.L., and Xian H. GABAergic cells and signals in CNS development. Perspectives on Developmental Neurobiology 5 (1998) 305-322
2. Ben-Ari Y., Cherubini E., Corradetti R., and Gaiarse J. Giant synaptic potentials in immature rat CA3 hippocampal neurons. Journal of Physiology-London 416 (1989) 303-325
3. Bittigau P., Sifringer M., Genz K., Reith E., Pospischil D., Govindarajalu S., Dzietko M., Pesditschek S., Mai I., Dikranian K., Olney J.O., and Ikonomidou C. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proceedings of the National Academy of Science USA 99 23 (2002) 15089-15094
4. Chaudhry F.A., Reimer R.J., Bellocchio E.E., Danbolt N.C., Osen K.K., Edwards R.H., and Storm-Mathisen J. The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. Journal of Neuroscience 18 23 (1998) 9733-9750
5. Dean J.C., Hailey H., Moore S.J., Lloyd D.J., Turnpenny P.D., and Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. Journal of Medical Genetics 39 4 (2002) 251-259
6. Dobbing J., and Sands J. Comparative aspects of the brain growth spurt. Early Human Development 3 1 (1979) 79-83
7. Dupuy S.T., and Houser C.R. Prominent expression of two forms of glutamate decarboxylase in the embryonic and early postnatal rat hippocampal formation. Journal Neuroscience 16 (1996) 6919-6932
8. Fernandez-Chacon R., Konigstorfer A., Gerber S.H., Gracia J., Matos M.F., Stevens C.F., Brose N., Rizo J., Rosenmind C., and Sudhof T.C. Synaptotagmin I function as a calcium regulator of release probability. Nature 410 (2001) 41-49
9. Fukuda M., and Mikoshiba K. Expression of synaptotagmin I or II promotes neurite outgrowth in PC12 cells. Neuroscience Letters 295 (2000) 33-36
10. Geppert M., Goda Y., Hammer R.E., Li C., Rosahl T.W., Stevens C.F., and Sudhof T.C. Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell 79 4 (1994) 717-727
11. Hansen D., and Lou H.C. Brain development, head circumference and medication. Acta Paediatrica 89 (2000) 505-507
12. Henderson N.D. Prior treatment effects on open field behavior of mice: a genetic analysis. Animal Behavior 15 (1967) 364-376
13. Holmes G.L., and Ben-Ari Y. The neurobiology and consequences of epilepsy in the developing brain. Pediatric Research 49 (2001) 320-325
14. Jahn R., and Sudhof T.C. Membrane fusion and exocytosis. Annual Review of Biochemistry 68 (1999) 863-911
15. Jin H., Wu H., Osterhaus G., Wei J., Davis K., Sha D., Floor E., Hsu C., Kopke R.D., and Wu J.Y. Demonstration of functional coupling between gamma-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proceedings of the National Academy of Science USA 100 7 (2003) 4293-4298
16. Levav T., Saar T., Berkovich L., and Golan H. Postnatal exposure to GABA-transaminase inhibitor impaired psychomotor function in the developing and adult mouse. International Journal of Developmental Neuroscience 22 3 (2004) 137-147
17. Ludwig A., Li H., Saarma M., Kaila K., and Rivera C. Developmental up-regulation of KCC2 in the absence of GABAergic and glutamatergic transmission. European Journal of Neuroscience 18 12 (2003) 3199-3206
18. Manabe T., Wyllie D.J., Perkel D.J., and Nicoll R.A. Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. Journal of Neurophysiology 70 4 (1993) 1451-1459
19. Manent J.B., Jorquera I., Mazzucchelli I., Depaulis A., Perucca E., Ben-Ari Y., and Represa A. Fetal exposure to GABA-acting antiepileptic drugs generates hippocampal and cortical dysplasias. Epilepsia 48 4 (2007) 684-693
20. Martin K.C., Hu Y., Armitage B.A., Siegelbaum S.A., Kandel E.R., and Kaang B.K. Evidence for synaptotagmin as an inhibitory clamp on synaptic vesicle release in Aplysia neurons. Proceedings of the National Academy of Science USA 92 24 (1995) 11307-11311
21. - cotransporter expression and inhibitory synaptogenesis in the rat hippocampus: an immunocytochemical analysis. European Journal of Neuroscience 15 2 (2002) 233-245
22. Morimoto T., Wang X.H., and Poo M.M. Overexpression of synaptotagmin modulates short-term synaptic plasticity at developing neuromuscular junctions. Neuroscience 82 4 (1998) 969-978
23. Owens D.F., and Kriegstein A.R. Is there more than GABA synaptic inhibition?. Nature Reviews, Neuroscience 3 (2002) 715-727
24. Pennuto M., Bonanomi D., Benfenati F., and Valtorta F. Synaptophysin I controls the targeting of VAMP2/synaptobrevin II to synaptic vesicles. Molecular Biology of the Cell 14 12 (2003) 4909-4919
25. Qiao M., Malisza K.L., Del Bigio M.R., Kozlowski P., Seshia S.S., and Tuor U.I. Effect of long-term vigabatrin administration on the immature rat brain. Epilepsia 41 6 (2000) 655-665
26. Quilichini P.P., Diabira D., Chiron C., Milh M., Ben-Ari Y., and Gozlan H. Effects of antiepileptic drugs on refractory seizures in the intact immature corticohippocampal formation in vitro. Epilepsia 44 11 (2003) 1365-1374
27. Qume M., Whitton S.P., and Fowler L.J. The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in-vivo release of GABA from rat hippocampus. Journal of Neurochemistry 64 (1995) 2256-2261
28. Rivera C., Voipio J., Payne J.A., Ruusuvuori E., Lahtinen H., Lamsa K., Pirola U., Saarma M., and Kaila K. The K/Cl co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Science 397 (1999) 251-255
29. Schulz P.E., Cook E.P., and Johnston D. Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. Journal of Neuroscience 14 9 (1994) 5325-5337
30. Scolnick D., Nulman I., Rovet J., Galdstone D., Czuchta D., Gardner H.A., Gladstone R., Ashby P., Weksberg R., Einarson T., et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. Journal of the American Medical Association 271 (1994) 767-770
31. Ullrich B., and Sudhof T.C. Differential distributions of novel synaptotagmins: Comparison to synapsins. Neuropharmacology 34 11 (1995) 1371-1377
32. Van der Pol M.C., Hadders-Algra M., Huisjes H.J., and Touwen B.C. Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. American Journal of Obstetrics and Gynecology 164 (1991) 121-128
33. Volpe J. Neurology of the Newborn. fourth ed. (2001), WB Saunders, Philadelphia 178-211
34. Wang C.T., Grishanin R., Earles C.A., Chang P.Y., Martin T.F., Chapman E.R., and Jackson M.B. Synaptotagmin modulation of fusion pore kinetics in regulated exocytosis of dense-core vesicles. Science 294 5544 (2001) 1111-1115